CRYBG1 and melanoma: Furthermore, the presence of either serum unmethylated LINE-1 or methylated AIM1 correlated with reduced survival (p = 0.0009), indicating the prognostic utility of these markers for predicting disease progression and patient outcomes in melanoma [105].